Osiris Therapeutics, Inc. (NASDAQ:OSIR)
CAPS Rating:
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
A stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, orthopedic and cardiovascular areas.
Recs
The only stem company that makes money. Huge deal with Genzyme. They are ready to double.
"The only stem company that makes money."That's a lie. They haven't EVER made a profit."Huge deal with Genzyme"That's a bigger lie."They are ready to double."There's a place in the penny-stock touting circle of hell waiting for you, you spineless garbage-touting POS.(GMX has no position in OSIR.)